Skip to main content
Caplight Logo









Nevakar Inc.

Nevakar Inc.

Private
Bridgewater, New JerseyHealthcare & Life Scienceshttp://nevakar.com/

Last Round

Convertible Debt

Mar 9, 2022

Total Funding Raised

$99.5M

Company Overview

Nevakar Inc. is a biopharmaceutical company that develops and commercializes innovative products for the ophthalmic and injectable areas.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

specialty pharmasterile injectablesdrug repositioning505(b)(2) pathwayready-to-use injectablespre-filled syringespharmaceutical out-licensingsupergenericsvalue-added medicinesdrug reformulationophthalmic productscritical care drugsdrug delivery systemsready-to-useRTU

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nevakar Inc. Comparables

Compare Nevakar Inc. with similar companies based on industry and business-model similarity.

Nevakar Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Rhoshan Pharmaceuticals, Inc.
78%
Hyloris Pharmaceuticals
76%
Pfizer
73%

Nevakar Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtMar 9, 2022
DebtOct 7, 2019
DebtJun 18, 2019
DebtNov 29, 2018
VC RoundJul 27, 2016

Key People

Founding team and executive leadership

George Zorich

CEO and Chairman of the Board, Board Member

Executive Team

Kumaresh Soppimath

President and CEO, President and CSO Nevakar Injectables

Executive Team

Nevakar Inc. Investors

Notable investors and investment history

Nevakar Inc. investors
InvestorRounds
NovaQuest Capital ManagementDebt
Oxford FinanceDebt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors grew 212% MoM, reaching 2.6K.

  • Jun 1, 2025

    Monthly visitors increased 80% MoM.

Nevakar Inc. Filings

Explore SEC and related filing metadata, where available.

Nevakar Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nevakar Inc.'s valuation, stock price, and market status.

Is Nevakar Inc. a public or private company?

Nevakar Inc. is a private company.

What is the current stock price of Nevakar Inc.?

Nevakar Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Nevakar Inc. worth (valuation)?

Valuation information for Nevakar Inc. is not publicly available.

Can I buy Nevakar Inc. stock?

Nevakar Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nevakar Inc.'s last funding round?

Funding round information for Nevakar Inc. is not publicly available.

Who are the main investors in Nevakar Inc.?

Investor information for Nevakar Inc. is not publicly disclosed.

Will Nevakar Inc. IPO soon?

No public IPO plans have been announced for Nevakar Inc..

How can I track Nevakar Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nevakar Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBridgewater, New Jersey
Employee Range36
Year Founded2015
Last FundingMar 9, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?